What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

Cancer research at VHIR

Coinciding with the World Cancer Day, we have prepared an interactive presentation about our research in oncology.

News

Dr Xavier de la Cruz leads a course on massive sequencing in biomedicine

The reseracher at VHIR, together with his team, has given the course in Madrid and Zaragoza, and will teach it at VHIR in the coming months.

News

VHIR researchers talk to the media about zika virus

Doctors Israel Molina and Diana Pou have been interviewed in several media to explain this disease that is affecting Central and South America.

News

VHIR will have a Business Advisory Board looking for new strategic opportunities

The Business Advisory Board will meet again in September to choose a President and deal with specific objectives.

News

Dr Rello has the highest h-index in critical care medicine in Spain

Dr Jordi Rello, head of the Clinical Research and Innovation in Pneumonia and Sepsis (CRIPS) at Vall d'Hebron Institute of Research (VHIR), is the researcher with the highest h-index in the field of critical care medicine in Spain, according to the http://indice-h.webcindario.com/" ranking publishe

News

VHIR hosts successful EATRIS combined platform meeting

The plenary discussions covered strategy and goals, ongoing platform activities in platform meetings, and served to assess the current state of the art in four emerging technology areas of relevance to translational research.

News

Dr Simó Schwartz Jr is appointed editor of the European Journal of Nanomedicine

Dr Simó Schwartz Jr, director of the CIBBIM-Nanomedicine at Vall d'Hebron Institute of Research (VHIR), has been appointed member of the editorial board of the http://www.degruyter.com/view/j/ejnm" European Journal of Nanomedicine. VHIR's researcher will review some of the manuscripts submitted to

News

New mechanism of antitumor action identified

A team of researchers from UAB, VHIR and Ability Pharmaceuticals describe a new pathway that might be use to design safer and more effective anti-tumour drugs.

News

It has never been possible before to do research so close to the Ebola virus

News

Padel for research in ulcerative colitis and Crohn’s disease

The Viladecans Padel Club and Lörd Padel have raised 3,000 euros for the research led by Dr. Francisco Guarner at VHIR.

News

VHIR participates in the first European network on chronic fatigue syndrome

The Chronic Fatigue group at Vall d'Hebron Institute of Research (VHIR) participates in the first European network on myalgic encephalomyelitis/chronic fatigue syndrome, called http://www.cost.eu/COST_Actions/ca/CA15111" EUROMENE. The network is a new action of the European Cooperation in Science a

News

New tools for the diagnosis of multiple sclerosis in its early stages

Scientists at CRG and VHIR develop a new method for early diagnosis of the disease. The finding makes it possible to accurately predict whether the patient will develop the disease.

News

Sandra Franco wins the National Graduation Award

The researcher of the Neurodegenerative Diseases group ended her university studies in Human Biology with a score of 9.4 out of 10, in 2012.

News

Dr. Santos writes a review about the genetic and epigenetic factors in irritable bowel syndrome

Nature Reviews has published the compilation of studies that VHIR's researcher has written together with the GENIEUR European consortium.

News

Craft beer for ovarian cancer

The Catalan Brewery 2D2Dspuma has produced 'Attack de Crab' to contribute to the Biomedical Research group in Gynecology.

News

Cell autophagy, a key process in muscle regeneration during ageing

News

Secondary school teachers come to VHIR to learn about lupus

Ten secondary school teachers participated last month in the course "Systemic lupus erythematosus: what is it? How can be treated? Let's find a cure!", taught by doctors Josefina Cortés and Cristina Solé, from the Systemic Diseases group at Vall d'Hebron Institute of Research (VHIR). The course is p